Age-related changes in the distribution pattern of glycosaminoglycans synthesized by cultured human diploid fibroblasts (WI-38)

A Preclinical Investigation into the Effects of Aging on Dermal Hyaluronan Properties and Reconstitution Following Recombinant Human Hyaluronidase PH20 Administration

INTRODUCTION

There is currently no consensus in the literature concerning the impact of aging on the properties of hyaluronan (HA) in the subcutaneous (SC) space. Recombinant human hyaluronidase PH20 (rHuPH20) facilitates SC administration of injected therapeutics by depolymerizing SC HA, facilitating bulk fluid flow, dispersion and absorption. This study assessed the impact of intrinsic aging on HA in the SC space and thus the ability of rHuPH20 to enhance delivery of co-administered therapeutics.

METHODS

Histologic evaluations of HA levels and degradation were performed on human skin samples from six age groups, aged from 20 to 100 years. HA levels were evaluated by HA staining and degradation by staining samples for HA following incubation with rHuPH20. HA was extracted from samples and HA size determined by gel electrophoresis. Dermal reconstitution was assessed in young (aged 1.5 months) and elderly (aged > 16 months) mice. Baseline dye dispersion was measured at 5 and 20 min post-intradermal dye injection. Following treatment with rHuPH20, dye dispersion was measured again at 2, 24, 48, 72 and 96 h.

RESULTS

Distribution of HA was confined to the interstitial space between adipocytes, with similar pericellular presence and levels of HA found across all age groups. Substantial levels of high-molecular-weight HA were observed in all age groups at baseline. Incubation with a clinically relevant dose of rHuPH20 resulted in degradation of all SC HA and similar degradation profiles independent of age. No difference in dye dispersion time was observed between young and elderly mice across the range of time points assessed, with dye dispersion returning to baseline levels by 24 h after rHuPH20 treatment.

CONCLUSIONS

Subcutaneous delivery of approved therapeutics facilitated by co-administration with rHuPH20 should not be impacted by intrinsic aging, with this study providing no evidence for an effect of aging on HA distribution, structure or a loss of rHuPH20 efficacy.

Aging is associated with reduced deposition of specific extracellular matrix components, an upregulation of angiogenesis, and an altered inflammatory response in a murine incisional wound healing model

The concept that aging impairs wound healing is largely unsubstantiated, the literature being contradictory because of poor experimental design and a failure to adequately characterize animal models. This study tested the hypothesis that aging retards the rate of wound repair using standardized cutaneous incisional wounds in a well-characterized aging mouse colony. Against the background of age-related changes in normal dermal composition, marked differences in healing were observed. Immunostaining for fibronectin was decreased in the wounds of the old mice, with a delay in the inflammatory response, re-epithelialization, and the appearance of extracellular matrix components. Heparan sulfate and blood vessel staining were both unexpectedly increased in the wounds of the old animals at late time points. Despite an overall decrease in collagen I and III deposition in the wounds of old mice, the dermal organization was surprisingly similar to that of normal dermal basket-weave collagen architecture. By contrast, young animals developed abnormal, dense scars. Intriguingly, some of these age-related changes in scar quality and inflammatory cell profile are similar to those seen in fetal wound healing. The rate of healing in young animals appears to be increased at the expense of the scar quality, perhaps resulting from an altered inflammatory response.

Werner syndrome: studies in an affected family reveal a cellular phenotype of unaffected siblings

Werner syndrome is an inherited disease with symptoms of presenescence. The primary defect site either on the protein or at the DNA level is not known, nor is it possible to identify a heterozygous phenotype. On the basis of cellular peculiarities expressed in the homozygotes-lifespan reduction of cells in culture, length of population doubling time and chromosomal instability-we searched for a 'Werner-like' phenotype in otherwise phenotypically unaffected siblings. We established primary fibroblasts from eight members of a Tyrolean family, two of whom had been diagnosed as typical Werner syndrome, as well as from unrelated healthy young and old volunteers. Determination of the lifespan of each strain and studies on population doubling time and chromosomal instability revealed similar cellular characteristics in all family members, albeit to a lesser extent with the siblings than with the homozygotes when compared to age-matched controls. These features, also apparent in cultivated fibroblasts from old but healthy controls, appear to be indicative of Werner syndrome when expressed in young or middle aged persons. The possible identification of otherwise clinically healthy gene carriers of Werner syndrome is of utmost importance for genetic counselling and medical surveillance for this disorder.

Stimulation of cell proliferation by hyaluronidase during in vitro aging of human skin fibroblasts

The effect of the degradation of extracellular hyaluronan on the proliferation of human skin fibroblasts in serial cultures during in vitro aging was investigated. Human skin fibroblasts at different time intervals from 3rd to 36th passages were exposed after plating to bovine testicular hyaluronidase. The enzyme treatment resulted in an increase in cell proliferation (cell number vs. time) as compared to the untreated control fibroblasts. The effect was dose dependent, reversible, and was independent of the type of the glycosidic linkage cleaved in hyaluronan. The increased proliferation was observed at all passages when untreated cells underwent mitosis. The degradation of hyaluronan induced cell proliferation up to the presenescent phase. Depletion of hyaluronan did not induce proliferation of postmitotic fibroblasts. The incorporation of 3H-glucosamine into hyaluronan decreased with increasing cell passages (increase of the number of population doublings). Twenty-fourth passage fibroblasts accumulated about two time less hyaluronan in the medium than ninth passage cultures. Following hyaluronidase treatment, the amount of newly synthesized, labeled hyaluronan increased in the medium. Accordingly, the fibroblasts restored the degraded hyaluronan even in the declining phase of proliferation (phase III according to Hayflick).

Drug-induced lysosomal storage of sulfated glycosaminoglycans in cultured bovine and human fibroblasts

Several di-cationic amphiphilic compounds are known to cause lysosomal accumulation of sulfated glycosaminoglycans (sGAG) in intact rats and in cultured rat fibroblasts. The purpose of the present investigation was to examine whether this drug side effect also occurs in bovine and human cells. Cultured fibroblasts from both species were exposed to tilorone (3 microM and 5 microM) for 72 h; lysosomal sGAG-storage was demonstrated by cytochemical staining with cuprolinic blue and by measuring the intracellular accumulation of [35S]-GAG. The cytological alterations as well as the radiochemical results in both species were in good agreement with previous data from rat fibroblasts. The present findings indicate that the drug-induced lysosomal storage of sGAG is a species-independent phenomenon. Thus, cultured bovine and human fibroblasts are a suitable model for further studies concerning the as yet unknown molecular mechanisms underlying this adverse drug action.

Cellular ageing related proteins secreted by human fibroblasts

Fibroblast secreted proteins participate in the formation of extracellular matrix. Extracellular matrix affects growth factor action, mediates cell adhesion and supports cell growth. Structural and quantitative characteristics of secreted proteins are modified in a similar manner, during both in vivo and in vitro cellular ageing. Such ageing related modifications may either be directly controlled by primary ageing causes, or evolve from a reformation of the extracellular matrix induced by a few ageing defects in key proteins such as fibronectin. They may result in the further inhibition of cell adhesion, cell stimulation by growth factors and, eventually, of cell proliferative ability.

Changes in the cell surface of human diploid fibroblasts during cellular aging

The electrophoretic mobility of 13 human diploid cell strains, TIG-1, TIG-2, TIG-3, TIG-7, WI-38, IMR-90, MRC-5, MRC-9, TIG-1H, TIG-1L, TIG-2M, TIG-2B, and TIG-3S, which were established from different tissues of human embryos, was studied at different passages. The net negative surface charge of the cells was characteristic for each cell strain and decreased significantly during the in vitro aging of the cells. The decrease in the net negative charge of the cells correlated well with the decrease in cell density throughout the life span of the cells. A strict linear correlation between the electrophoretic mobility and the number of cells harvested at each passage was obtained for all the human diploid cell strains. Moreover, almost the same linear regression coefficient of the cells was obtained among these cell strains. Therefore, the net negative surface charge of human diploid cell strains could serve as a cell surface marker for in vitro cellular aging.

In vitro cultures of trabecular meshwork cells of the human eye as a model system for the study of cellular aging

Cells from the human trabecular meshwork providing a drainage system for the outflow of aqueous humour in the eye were isolated and propagated in monolayer culture. Following serial subcultivation of the primary cultures, there was a gradual decline in the fraction of dividing cells with increasing population doubling level (PDL) resulting finally in growth cessation and disintegration of these 'senescent' cultures. The number of population doublings was at most 20. Senescent cultures revealed reduced glycosaminoglycan synthesis rates (as measured by [14C]glucosamine incorporation) with a relative decrease of hyaluronic acid and increase of heparan sulfate. Medium-supplied (exogenous) hyaluronic acid enhanced hyaluronic acid synthesis of trabecular meshwork cells cultured in a defined, serum-free medium. Ascorbic acid (25-200 micrograms/ml), which is found in very high concentration in the ocular aqueous humour, stimulated hyaluronic acid synthesis of confluent cultures, also. The functional significance of decreased hyaluronic acid (and elevated heparan sulfate) synthesis in the process of cellular aging in vitro (and in vivo?), as well as the importance of hyaluronic acid for the structural integrity and functional activity of the trabecular meshwork were discussed.

A decrease in hyaluronic acid synthesis by aging human fibroblasts leading to heparan sulfate enrichment and growth reduction

Cultured normal human fibroblasts during in vitro aging exhibited increased proportions of heparan sulfate (HS; a glycosaminoglycan (GAG) species) in the cell-associated GAG pool, coincident with decreased cell growth activity. An analysis of GAG metabolism demonstrated that human fibroblasts during aging became relatively rich in HS due to an alteration in the profile of GAG synthesis. HS became relatively enriched and hyaluronic acid (HA) relatively depleted through a decrease in HA synthase activity. An experimental enrichment of human fibroblast cultures with exogenous HS brought about an arrest of the cells in the G0/G1 phase and a decrease in the rate of S phase entry, coincident with aged cell growth behaviour. These results suggest that the change in HA synthesis is responsible, at least to some extent, for the growth reduction during aging of normal human fibroblasts.

Potential and limitations of cultivated fibroblasts in the study of senescence in animals. A review on the murine skin fibroblasts system

Senescence is the last period of the life span, leading to death. It happens in all animals, with the exception of a few didermic species (Hydras) having a stock of embryonic cells and being immortal. The causes of animal senescence are badly known. They depend both on genetic characters (maximum life span of a species) and on medium factors (mean expectation of life of the animals of a species). Animal senescence could depend on cell aging: (1) by senescence and death of the differentiated cells, (2) by modified proliferation of the stem cells of differentiated tissues, (3) by alterations in the extracellular matrices, (4) by interactions between factors (1) (2) and (3) in each tissue, and (5) by interactions between the several tissues of an organism. This complexity badly impedes the experimental study of animal senescence. Normal mammal cells are aging when they are cultivated (in vitro aging). Present literature upon in vitro aging of cultivated human fibroblasts consists essentially of papers devoted to proliferation and differentiation characteristics and not to cell senescence. Murine skin fibroblasts have been studied in our laboratory, using different systems: (1) primary cultures isolated from peeled skins of mouse embryos, (2) mouse derms analysed in the animals, (3) cultivated explants of skins, (4) serial sub-cultures of fibroblasts isolated from these explants, (5) cells cultivated comparably on plane substrates (glass, plastic, collagen films) and on three-dimensional matrices (collagen fibres). In primary cultures (system 1) all the cell generations have been analysed, including the last one until death of the culture. We have shown that many characters are varying with cell generation. All the observed variations were: progressive, non-linear and correlated (intracellular feedbacks). We come to the conclusion that the main effects of cell mitotic age are (1) to depress the plasticity of the chromatin, (2) to change the organization of the cytoplasmic filaments, (3) to change the organization of the extracellular matrix. The collagen fibres are also acting upon nucleus and filaments either in the animals or in the cultures. The phenotype of a fibroblastic cell is thus both age- and environment-dependent. Overall data on in vitro cell aging point to the hypothesis that senescent cells are phenotypic variants and not mutant cells. Aging cell cultures are remarkably useful to the studies on cell proliferation decrease and cell cycle lengthening shown by the stem cells in animal tissues. We propose the hypothesis that the fibroblasts of the vertebrates would be homologous to the pluripotent mesenchyme cells of their embryos.

Exogenous glycosaminoglycans stimulate hyaluronic acid synthesis by cultured human trabecular-meshwork cells

Addition of hyaluronic acid (50-200 micrograms ml-1) to the defined, serum-free media of cultured human trabecular-meshwork cells resulted in an increase of glycosaminoglycan (GAG) synthesis as measured by the incorporation of [14C]glucosamine. Lesser stimulatory effects were exerted by dermatan sulfate and chondroitin-4- or -6-sulfate. Nearly 90% of the labeled GAGs were found to be exerted into the medium and ea. 10% were associated with the cell layer. Mainly hyaluronic acid synthesis was stimulated by the exogenous GAGs. Analysis of the GAG-pattern revealed that exogenous hyaluronic acid stimulated hyaluronic acid synthesis (positive feedback), while exogenous dermatan sulfate and chondroitin sulfate had additional effects on chondroitin sulfate synthesis. Cell growth of these cultures, which exhibited a limited proliferative capacity (ca. 18 population doublings during their life span) was not affected by the GAG treatment. Thus, exogenous hyaluronic acid and to a lower degree dermatan sulfate or chondroitin sulfate appeared to interfere with the GAG-metabolism of these human trabecular-meshwork cells in culture.

Hyaluronate synthetase inhibition by normal and transformed human fibroblasts during growth reduction

To establish the relation of glycosaminoglycan synthesis to cell proliferation, we investigated the synthesis of individual glycosaminoglycan species by intact cells and in a cell-free system, using normal and transformed human fibroblasts under differing culture conditions. Reducing serum concentration brought about a marked decline in the synthesis of hyaluronate (HA) as well as cell proliferation on both normal and transformed cells. Both HA synthesis and proliferation decreased with increasing cell densities markedly (in inverse proportion to cell density) in normal cells but gradually in transformed cells. This noticeable congruity of the changes in HA synthesis and proliferation indicates that the change in HA synthesis is related primarily to cell proliferation rather than to cell density or cellular transformation. Examination of HA synthesis in a cell-free system demonstrated that the activity of HA synthetase also fluctuated in conjunction with cell proliferation. Furthermore, growth-reduced cells (except crowded transformed cells) inhibited cell-free HA synthesis and this inhibition was induced coincidentally with a decrease in both HA synthetase activity and proliferation. These findings suggest that the change in HA synthesis is significant in the regulation of cell proliferation.

Cellular senescence revisited: a review

The field of cellular senescence (cytogerontology) is reviewed. The historical precedence for investigation in this field is summarized, and placed in the context of more recent studies of the regulation of cellular proliferation and differentiation. The now-classical embryonic lung fibroblast model is compared to models utilizing other cell types as well as cells from donors of different ages and phenotypes. Modulation of cellular senescence by growth factors, hormones, and genetic manipulation is contrasted, but newer studies in oncogene involvement are omitted. A current consensus would include the view that the life span of normal diploid cells in culture is limited, is under genetic control, and is capable of being modified. Finally, embryonic cells aging in vitro share certain characteristics with early passage cells derived from donors of increasing age.

Changes in the higher order organization of DNA during aging of human fibroblast-like cells

Nucleosome spacing (DNA repeat length) was determined in human diploid fibroblast-like cells (HDF) of different in vitro ages following the electrophoretic separation of micrococcal nuclease digestion products. The results indicate that a heterogeneity of DNA repeat lengths is present in HDF of all in vitro ages. In older cells the organization of part of the DNA is conserved, but a greater proportion of shorter repeats is evident. The shorter repeat lengths are not due to nucleosome sliding, but result from the presence of shorter linker regions which are reduced by as much as 25% in part of the chromatin of high PDL cells.

Proteoglycans in the substratum adhesion sites of human papillary or reticular dermal fibroblasts. Aging in vivo or in vitro

Sulfate-radiolabeled proteoglycans (PG) have been characterized from the tissue culture substratum adhesion sites of two human dermal fibroblast subpopulations, papillary (PAP) or reticular (RET), to determine the consequences of aging of these cells either in vivo or in vitro upon properties of these cells: matrix interfacing molecules. Cells were isolated from a 1-day-old male infant (patient 5) and a 78-year-old male (patient 8) and, after longterm radiolabeling in culture, detached from the substratum by EGTA treatment. The substratum adhesion sites were then extracted with a mixture of 1% octylglucoside, 1 M NaCl, and 0.5 M guanidine hydrochloride (GdnHCl) in acetate buffer with various protease inhibitors; these reagents quantitatively solubilize PG from adhesion sites and can be readily removed to test biological activities. PAP adhesion sites contained significantly more free chains of glycosaminoglycan than the sites of RET cells. Fractionation on DEAE-Sepharose columns under two different sets of gradient elution conditions [DEAE-I in which only acetate buffer was used; or DEAE-II in which acetate buffers were supplemented with 8 M urea] identified two major classes of PG in both PAP and RET cells - heparan sulfate proteoglycan (HS-PG) and chondroitin, dermatan sulfate proteoglycans (CS, DS-PG) - with an increased proportion of HS-PG in cells which had aged in vivo or in vitro (late-passage cells also generate a low molecular weight component that resolves on these columns). On DEAE-I columns, 70-80% of the PG forms high molecular weight aggregates that require high concentrations of urea or GdnHCl for further fractionation (DEAE-II conditions). Subsequent fractionation of the two PG classes was performed using three affinity chromatography systems. On platelet factor-4 (PF4) Sepharose columns, the HS-PGs from all cells studied bound completely and eluted with considerable heterodispersity. The CS, DS-PGs from middle-passage cells bound completely to PF4 as well but gave a more homodisperse pattern of elution; in contrast, late-passage (in vitro-aged) adhesion sites contained CS, DS-PGs that were more heterodisperse and that contained a high-avidity class. On plasma fibronectin (pFN)-Sepharose columns, the HS-PGs of middle or late-passage cells bound completely and eluted with a homodisperse pattern; in contrast, the HS-PGs from in vivo-aged cells contained 15-20% of their molecules which failed to bind to the column and a small subset which bound with greater avidity.(ABSTRACT TRUNCATED AT 400 WORDS)

Proteoglycans synthesized by gingival fibroblasts derived from human donors of different ages

The proteoglycans synthesized by fibroblasts derived from human donors of ages ranging from 12 years to 68 years have been studied. In addition, the in vitro proliferation rates of the various cell strains were studied and demonstrated that increasing donor age correlated with a decrease in proliferative activity. The incorporation of [35S]-sulfate into proteoglycans decreased with increasing donor age with cells from the oldest donor demonstrating a 50% reduction compared with cells from the youngest donor. Analysis on Sepharose CL-4B of isolated [35S]-labeled proteoglycans for molecular size distribution revealed few differences between the cell-layer-associated proteoglycans of all cell strains studied. However, analysis of the medium-associated [35S]-labeled proteoglycans demonstrated an increase in the amount of small molecular size proteoglycans with increasing age. More specific analysis of the glycosaminoglycan composition revealed an increase in heparan sulfate from 52% to 73% in the cell-layer-associated proteoglycans of cells from the youngest and oldest donors, respectively. Accompanying this increase was a relative decrease in dermatan and chondroitin sulfate content from 24% to 13% and 25% to 16%, respectively, with increasing donor age. Additionally, the degree of N-sulfation of cell layer heparan sulfate increased with age. Heparan sulfate levels increased in the medium as well with increasing age, with a concomitant decrease in chondroitin sulfate. The quantity of medium-derived dermatan sulfate remained relatively evenly distributed throughout the various ages studied. The various differences noted are considered to reflect the general metabolic changes associated with aging. In particular the increase in heparan sulfate content with age is considered to be related to the decreased proliferative activity of the fibroblasts with increasing age.

Glycosaminoglycan distribution in substratum adhesion sites of aging human skin fibroblasts, including papillary and reticular subpopulations

Glycosaminoglycan (GAG) distribution has been analyzed in the adhesion sites, left substratum-bound after EGTA-mediated detachment, of various human skin fibroblast populations grown in vitro in the presence (asc+) or absence (asc-) of ascorbate. Examination of these skin fibroblasts during the EGTA treatment by scanning electron microscopy reveals that (a) asc+ cells detach much more rapidly than asc- cells, but (b) asc- or asc+ cells leave the same two types of structures in longterm culture-generated substratum-attached material (L-SAM)--long linear retraction fibers and "footpad-like" structures. Most of the [3H]glucosamine-radiolabeled polysaccharides in L-SAM were shown to be GAGs. Fibroblasts from a full-thickness skin sample from a very young patient (AG4449) have similar distributions of the GAGs in both the EGTA-suspended cell and L-SAM fractions; however, asc+ cell and L-SAM fractions contain relatively more heparan sulfate than the asc- fractions. In contrast, full-thickness skin fibroblasts from an elderly patient (AG2261) generate GAG distributions in their L-SAMs (with greatly elevated levels of hyaluronate and chondroitin sulfate) that are very different from those of the cell fractions and from those of AG4449; furthermore, these distributions in AG2261 fractions do not change when shifted from asc- to asc+ medium. These studies led to analyses of the two major fibroblast subsets--papillary (PAP) or reticular (RET)--that can be isolated from the dermis of a newborn infant (patient 5). The GAG distributions in the RET fractions were different from those in PAP fractions; of special note was the greater length of heparan sulfate chains from all RET fractions examined when compared to PAP fractions. There was a remarkable similarity in the GAG distributions of asc+ RET fractions when compared to the full-thickness AG2261 cell fractions. In summary, these studies demonstrate that asc- or asc+ "young" cells generate different GAG distributions in their substratum adhesion sites, whereas "old" cells from a full-thickness skin sample do not alter their distribution when shifted from asc- to asc+ (this distribution is different from that of "young" cells). Furthermore, analyses of GAGs in papillary and reticular cell fractions reveal significant differences between the two, with considerable similarity of asc+ reticular fractions to the full-thickness AG2261 fibroblasts, which is consistent with the enrichment of reticular fibroblasts in the skin of aging individuals.

Glycosaminoglycan synthesis in untransformed and transformed Werner syndrome fibroblasts: a preliminary report

Glycosaminoglycan (GAG) synthesis was studied in untransformed and transformed normal and Werner syndrome (WS) fibroblasts, because WS manifests pleiotropic abnormalities in connective tissue. Continuous labelling of cells with [3H] glucosamine and [35S] sulfate for 48 hours revealed enhanced synthesis of cellular GAG, more rapid transfer of these into the pericellular fraction, and more accumulation of GAG in the medium in cultures of untransformed WS fibroblasts compared with cultures of normal diploid cells. Total GAG in the 24 hour medium from confluent cultures was composed of 80-90% hyaluronic acid (HA) and 10-20% sulfated GAG (S-GAGs) in both untransformed normal and WS fibroblasts, whereas it was approximately 50% each HA and S-GAG in transformed normal and WS cells. The proportional enhancement of [35S] GAG synthesis in response to exogenous beta-D-xylopyranosides was similar in normal and WS cells, although transformed cells demonstrated only approximately one-half the enhancement observed in non-transformed cells. Thus, the overall activity of GAG synthesis is not grossly altered by the WS gene mutation. Enhanced synthesis and accumulation of HA and dermatan sulfate (DS) in the medium was characteristic of untransformed WS fibroblasts, but appeared to be normalized in an SV40-transformed WS cell line (PSV811), as in transformed normal cells (WI38CT-1). We need more experiments to determine whether aberrant GAG metabolism in WS cells is a direct or indirect expression of the primary gene defect.

Cell surface changes in senescent and Werner's syndrome fibroblasts: their role in cell proliferation

Cell surface is known to participate in the regulation of cell proliferation through interaction with adjacent cell surfaces or the extracellular matrix, or both. A clinical survey of the Werner syndrome suggests some disorders in glycosaminoglycan metabolism. Also, the skin fibroblasts derived from the patients with WS have a reduced proliferation capacity. We here examined, in vitro and in vivo, alterations of the cell-surface properties of WS cells and aging human fibroblasts. Cell-surface negative charges, examined by electrophoretic mobility of dispersed single cells in buffer, were seen to decline steadily as a function of cumulative population doublings. A strict linear relationship was found between electrophoretic mobility (micron/sec/V/cm) and number of cells harvested at each passage in all cell lines examined. The slope of this line in cells from donors of different ages indicated that WS fibroblasts resemble cells from much older normal controls. The same conclusion was drawn from our previous study of Con A-mediated red cell adsorption, which was confirmed as reflecting an alteration of cell-surface coat negative charge. Electrophoretic mobility after treatment of cell surface with degradative enzymes showed that the cell-surface negative charges were attributable to sialic acid, chondroitin sulphates, hyaluronic acid, and heparan sulphate. Two-dimensional electrophoresis of 3H-glucosamine incorporated glycosaminoglycans (GAGs) revealed that heparan sulphate was the main component of GAGs on the fibroblast cell surface and that the relative amount of heparan sulphate among GAGs on the cell surface increased in vitro with the number of passages. Growth kinetics of fibroblasts on sheets of fixed cells treated with a fixative (glutaraldehyde) and degradative enzymes were examined to elucidate the role of cell-surface GAGs in the regulation of cell proliferation. Cell growth was inhibited 40% when the fibroblasts were cultured on the fixed sheets of late passage cells. Treatment of the fixed cell sheets with heparitinase or nitrous acid resulted in complete recovery from the growth inhibition. Cell growth on sheets of fixed cells derived from young, middle, and senescent fibroblasts showed that the surface of the senescent cells had the greatest inhibitory effect. These inhibitory effects of fixed cell sheets correlated well with both the amount of heparan sulphate relative to the total GAGs on the surface and to the saturation density of cell growth at each passage. These findings strongly suggest that heparan sulphate, or its complex, on the cell surface is involved in the regulation of cell proliferation.(ABSTRACT TRUNCATED AT 400 WORDS)

Synthesis and composition of glycosaminoglycans by explant cultures of human ciliary body and ciliary processes in serum-containing and serum-free defined media

Freshly isolated ciliary body explants and tips of ciliary processes derived from human eyes were cultured in serum-containing or serum-free defined medium. These cultures synthesized tissue-bound and medium-released ("excreted") glycosaminoglycans (GAGs), as evidenced by the incorporation of 14C-glucosamine and enzymatic characterization of these labelled GAGs (hyaluronic acid, heparan sulphate, chondroitin sulphate, dermatan sulphate). The GAG synthesis and excretion rate was enhanced by serum. It is suggested that ciliary epithelium performs this function of GAG synthesis also under in vivo conditions.

Glycosaminoglycans in the basal lamina and extracellular matrix of serially aged mouse mammary ducts

The synthesis and accumulation of specific glycosaminoglycans into proteoglycans of the basal lamina and extracellular matrix is an important aspect of ductal growth and branching morphogenesis in the mouse mammary gland. The present study was undertaken to determine whether serially aged mammary gland, which has lost most of its growth potential during repeated transplantation, displays altered ability to synthesize and accumulate glycosaminoglycans into the extracellular matrix or basal lamina. Using histochemical and autoradiographic procedures coupled with enzymatic digestion, it is now shown that serially aged mammary ductal tissue synthesizes and incorporates hyaluronate into the basal lamina at the leading edge of the end bud, where growth takes place, and sulfated glycosaminoglycans are accumulated in the extracellular matrix along the end bud flanks, associated with ductal morphogenesis. These patterns of synthesis and accumulation are similar to those associated with the growth of young gland. In non-growing regions, regardless of whether growth termination resulted from serial aging or from normal growth regulatory mechanisms operating in the young gland, sulfated glycosaminoglycans were distributed in the extracellular matrix around the ductal tips. Again, the pattern was similar in young and serially aged gland. We conclude that glycosaminoglycan metabolism and distribution are related to growth status rather than tissue age, and are unlikely to be an important component of mammary senescence.

Synthesis and composition of glycosaminoglycans by cultured human trabecular meshwork cells

A human trabecular meshwork cell line with a limited number of population doublings was established in monolayer culture. All cultures produced hyaluronic acid, heparan sulfate, chondroitin sulfate, and dermatan sulfate. Following [14C]-glucosamine incorporation into proliferating (phase II) cultures, 70%--80% of the medium glycosaminoglycan label was found in hyaluronic acid and 8%--14% in heparin sulfate. About 60% of the cell-bound activity was associated with hyaluronic acid and 30% with heparan sulfate. Long-term cultivation under nondividing ("senescent") conditions resulted in a change of the pattern of synthesized and excreted (medium) [14C]-glucosamine-labeled glycosaminoglycans with a relative decrease of hyaluronic acid and a relative increase of heparan sulfate.

Werner's syndrome: a review of recent research with an analysis of connective tissue metabolism, growth control of cultured cells, and chromosomal aberrations

Werner's syndrome is a rare, autosomal recessive condition with multiple progeroid features, but it is an imitation of aging rather than accelerated or premature senescence. Somatic chromosome aberrations occur in multiple tissues in vivo and in vitro, and there is an increased incidence of neoplasia. Thus. Werner's syndrome can be classified in the group of chromosome instability syndromes. Recent findings provide additional support for the concept that there is an aberration of connective tissue metabolism in Werner's syndrome, but it is unclear whether this is a primary or secondary manifestation of the underlying genetic defect. Abnormal growth characteristics are observed in cultured skin fibroblast-like cells and this provides another avenue for current research. Identification of the basic genetic defect in Werner's syndrome might clarify our understanding of the normal aging process in general, or might elucidate specific aspects such as the development of neoplasia, atherosclerosis, diabetes, or osteoporosis.